Rhamnolipoide esters as non-ionic surfactants for cosmetic use

Description

Field of the invention

[0001] The invention relates to ester derivatives of rhamnolipids, formulations containing them and their use. State of the art

[0002] Rhamnolipids are surfactants that can be produced by fermentation. They consist of one to two rhamnose units and one to three, usually β-hydroxy fatty acids. The fatty acids can be saturated or unsaturated. The variation in chain length and quantity (congeners) of the fatty acid moieties has been described in several publications (Howe et al., FEBS J. 2006; 273(22):5101-12; Abdel-Mawgoud et al., Appl Microbiol Biotechnol, 86, 2010; pp. 1323-1336). Few covalent derivatives of the fatty acid moieties of rhamnolipids are known. Mainly, a few rhamnolipid esters have been described in the literature. Hirayama et al., FEBS Letters, Volume 139, Issue 1, 1982; Pages 81-85, describes the identification of rhamnolipid methyl esters in liquid cultures of Pseudomonas aeruginosa.Miao et al., Journal of Surfactants and Detergents, 17 (6), 2014; 1069-1080, describes the synthesis of di-rhamnolipid ethyl ester by esterification with ethanol. Miao et al., European Journal of Lipid Science and Technology, 117, 2015; 156-160, describes the preparation of biopolyurethanes from di-rhamnolipid ethyl ester.

[0003] WO2001010447 and EP1889623 disclose the pharmaceutical and cosmetic applications of rhamnolipids and short-chain rhamnolipid esters (C1-C6; methyl to hexyl esters, linear or branched), particularly in wound healing.

[0004] Furthermore, the chemical synthesis of rhamnolipids is described in Duynstee et al., European Journal of Organic Chemistry, 2, 1998; 303-307, and in Bauer et al., Chem. Eur. J. 12, 2006; 7116-7124; phenacyl esters and benzyl esters of rhamnolipids are presented as intermediates.

[0005] Miao et al. disclose in Journal of Surfactants and Detergets (2014), vol. 17, no. 6, pages 1069 - 1080 , the ethylation of rhamnolipids.

[0006] The object of the invention was to provide substances that create a soft skin feeling after shaving that lasts for a long time. Description of the invention

[0007] Surprisingly, it was found that the rhamnolipid esters described below are able to achieve the object of the invention.

[0008] The present invention therefore relates to rhamnolipid esters as set out in claim 1.

[0009] Another object of the invention is a process for producing the rhamnolipid esters according to the invention and their use.

[0010] An advantage of the present invention is that after application of the formulations according to the invention, the smooth, silky-soft skin feeling directly after shaving is maintained for significantly longer than after application of formulations not according to the invention.

[0011] Another advantage of the present invention is that after application of the formulations according to the invention, the skin is less degreased.

[0012] A further advantage of the present invention is that the rhamnolipid esters according to the invention increase the mildness of formulations.

[0013] Another advantage of the present invention is that the formulations according to the invention can eliminate unwanted odors from skin while leaving the skin feeling good.

[0014] A further advantage of the present invention is that the compositions according to the invention improve skin elasticity.

[0015] Another advantage is that the manufacturing process is very mild and gentle, so that the desired sugar structure is not destroyed, but esterification is still possible.

[0016] Another advantage is that the product is excellently suited to insulation and processing.

[0017] The terms "rhamnolipid" and "rhamnolipid ester" in the context of the present invention always include their corresponding salts.

[0018] The term "rhamnolipid ester" in the context of the present invention refers to compounds of the general formula (I), where m = 2, 1 or 0, in particular 1 or 0, n = 1 or 0, in particular 1, R 1< = organic radical having 2 to 24, preferably 5 to 13 carbon atoms, in particular optionally branched, optionally substituted, in particular hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, R 2< = independently of one another identical or different organic radicals having 2 to 24, preferably 5 to 13 carbon atoms, in particular optionally branched, optionally substituted, in particular hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, Alkyl radical, preferably selected from the group consisting of pentenyl, heptenyl, nonenyl,Undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, and R 3< = aliphatic radical having 7 to 32 carbon atoms, particularly preferably 8 to 24 carbon atoms, especially particularly preferably 10 to 18 carbon atoms. characterized in that R 3 is selected from the group of radicals R 3 derived from OHR 3 = natural fatty alcohol. ,

[0019] The term "mono-rhamnolipid" in the context of the present invention refers to compounds of the general formula (I) with R 3< = H or salts thereof, where n = 0. Distinct rhamnolipids are abbreviated according to the following nomenclature: "diRL-CXCY" refers to di-rhamnolipids of the general formula (I) with R 3< = H or salts thereof, where one of the radicals R 1< and R 2< = (CH 2 ) o -CH 3 with o = X-4 and the remaining radical R 1< or R 2< = (CH 2 ) o -CH 3 with o = Y-4.

[0020] "MonoRL-CXCY" means mono-rhamnolipids of the general formula (I) with R 3< = H or their salts, in which one of the radicals R 1< and R 2< = (CH 2 ) o -CH 3 with o = X-4 and the remaining radical R 1< or R 2< = (CH 2 ) o -CH 3 with o = Y-4.

[0021] The nomenclature used therefore does not distinguish between "CXCY" and "CYCX".

[0022] For rhamnolipids with m=0, monoRL-CX or diRL-CX is used accordingly.

[0023] If one of the above-mentioned indices X and / or Y is provided with ":Z", this means that the respective radical R 1< and / or R 2< = represents an unbranched, unsubstituted hydrocarbon radical with X-3 or Y-3 carbon atoms and Z double bonds.

[0024] Analogous nomenclature is used for rhamnolipid esters in the form di / monoRL-CXCY:Z-ester.

[0025] The "pH value" in the context of the present invention is defined as the value measured for the corresponding substance at 25 °C after five minutes of stirring with a pH electrode calibrated according to ISO 4319 (1977).

[0026] All percentages (%) are by mass unless otherwise stated.

[0027] The present invention relates to rhamnolipid esters of the general formula (I), where m = 2, 1 or 0, in particular 1 or 0, n = 1 or 0, in particular 1, R 1< = organic radical having 2 to 24, preferably 5 to 13 carbon atoms, selected fromoptionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, R 2< = independently of one another identical or different organic radical having 2 to 24, preferably 5 to 13 carbon atoms, selected from optionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, and R 3< = aliphatic radical having 7 to 32 carbon atoms, preferably 8 to 24 carbon atoms, particularly preferably 10 to 18 carbon atoms, characterized in that R 3 is selected from the group of residues R 3 derived from OHR 3 = natural fatty alcohol.

[0028] In this context, rhamnolipid esters are particularly preferably selected according to the invention from diRLC10C10 esters, diC8C10 esters, diRLC10C12 esters, diRLC10C12:1 esters and monoRLC10C10 esters.

[0029] The term "natural fatty alcohol" in the context of the present invention refers to the alcohols obtainable by reducing natural triacylglycerols, fatty acids, or fatty acid methyl esters; these include, in particular, linear, saturated, or unsaturated primary alkan-1-ols having 8-32 carbon atoms.

[0030] Particularly preferred rhamnolipid esters according to the invention are characterized in that R 3< is selected from branched or linear alkyl radicals, preferably having 8 to 22, in particular 12 to 18, carbon atoms. In this context, rhamnolipid esters are particularly preferably selected from diRLC10C10 esters, diRLC8C10 esters, diRLC10C12 esters, diRLC10C12:1 esters, and monoRLC10C10 esters.

[0031] Particularly preferred rhamnolipid esters according to the invention are characterized in that R 3< is selected from the group comprising, preferably consisting of, lauryl, myristyl, palmityl, and stearyl residues. In this context, rhamnolipid esters are particularly preferably selected according to the invention from diRLC10C10 esters, diRLC10C12 esters, diRLC10C12:1 esters, and monoRLC10C10 esters.

[0032] The rhamnolipid esters according to the invention are preferably mixture compositions of rhamnolipid esters, which are characterized in particular by the fact that they contain mono- and di-rhamnolipid esters.

[0033] Depending on the application, it may be preferred that the mixture compositions according to the invention contain more weight percent of mono-rhamnolipid esters than di-rhamnolipid esters or more weight percent of di-rhamnolipid esters than mono-rhamnolipid esters, wherein the weight percents relate to all mono- and di-rhamnolipid esters contained in the mixture composition.

[0034] For example, the mixture compositions according to the invention can contain more than 60% by weight, in particular more than 80% by weight, or even more than 95% by weight, of di-rhamnolipid esters, or also more than 60% by weight, in particular more than 80% by weight, or even more than 95% by weight, of mono-rhamnolipid esters, wherein the weight percentages refer to all mono- and di-rhamnolipid esters contained in the mixture composition.

[0035] Another object of the present invention is a process for producing the inventive Rhamnolipid esters comprising the process steps A) Providing at least one rhamnolipid, B) reacting the rhamnolipid with at least one coupling reagent, C) reacting the rhamnolipid activated by process step B) with an alcohol selected from the group of aliphatic alcohols with 7 to 32 carbon atoms and fatty alcohols , and optionally D) purifying the rhamnolipid ester.

[0036] Process step A) is carried out according to generally known methods of the prior art, in particular using genetically modified microorganisms that preferentially overexpress rhamnolipid synthesis genes, wherein these genes are preferably selected from rhlA, rhlB, and rhlC. The skilled person can find corresponding instructions in, for example, US2014296168 and WO2012013554.

[0037] It is preferred according to the invention that in process step B) at least one coupling reagent selected from the group comprising, preferably consisting of, dicyclohexylcarbodiimide, diisopropylcarbodiimide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-cyclohexyl-N'-(2'-morpholinoethyl)carbodiimide metho-p-toluenesulfonate, N-benzyl-N'-3' dimethylaminopropylcarbodiimide hydrochloride, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide N-ethylcarbodiimide hydrochloride and carbonyldiimidazole, particularly preferably dicyclohexylcarbodiimide and diisopropylcarbodiimide, is used.

[0038] Likewise, it is preferred according to the invention that in process step C) at least one catalyst selected from the group comprising, preferably consisting of, N-ethyldiisopropylamine, trialkylamines, pyridine, 4-dimethylaminopyridine and hydroxybenzotriazole, in particular hydroxybenzotriazole, is used.

[0039] Processes according to the invention lead to rhamnolipid esters of the general formula (I), where m = 2, 1 or 0, in particular 1 or 0, n = 1 or 0, in particular 1, R 1< = organic radical having 2 to 24, preferably 5 to 13 carbon atoms, selected fromoptionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, R 2< = independently of one another identical or different organic radical having 2 to 24, preferably 5 to 13 carbon atoms, selected fromoptionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, di- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undekenyl and tridekenyl and (CH 2 ) o -CH 3 with o = 1 to 23, preferably 4 to 12, and R 3< = aliphatic radical having 7 to 32 carbon atoms, particularly preferably 8 to 24 carbon atoms, especially particularly preferably 10 to 18 carbon atoms, characterized in that R 3< is selected from the group of radicals R 3< derived from OHR 3< = natural fatty alcohol, and particularly preferably to the rhamnolipid esters described above as being particularly preferred according to the invention.

[0040] For example, in process step A), rhamnolipids selected from diRLC10C10, diC8C10, diRLC10C12, diRLC10C12:1 and monoRLC10C10 or mixtures thereof are preferably used.

[0041] The rhamnolipid esters according to the invention can be advantageously incorporated in particular into cosmetic formulations, preferably for shaving applications.

[0042] Thus, a further object of the present invention is the Use of the rhamnolipid esters according to the invention for producing formulations, in particular cosmetic formulations, as well as the formulations themselves, in particular cosmetic formulations, preferably for shaving applications, which contain the rhamnolipid esters according to the invention.

[0043] The formulations according to the invention are preferably aqueous formulations.

[0044] The term "aqueous formulation" in the context of the present invention is understood to mean a formulation which contains at least 5% by weight of water, based on the total composition under consideration.

[0045] It is preferred according to the invention if the formulations according to the invention contain the rhamnolipid esters according to the invention in an amount of 0.05 wt.% to 40 wt.%, preferably from 0.2 wt.% to 20 wt.%, particularly preferably from 0.5 wt.% to 12 wt.%, wherein the weight percentages relate to the total formulation.

[0046] Preferred formulations according to the invention contain, in addition to the rhamnolipid esters according to the invention, at least one further surfactant, whereby, for example, anionic, nonionic, cationic, and / or amphoteric surfactants can be used. From an application perspective, mixtures of anionic and nonionic surfactants are preferred. The total surfactant content of the aqueous formulation is preferably 5 to 60 wt.% and particularly preferably 15 to 40 wt.%, based on the entire formulation.

[0047] Nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, especially primary alcohols with preferably 8 to 18 carbon atoms and an average of 1 to 12 moles of ethylene oxide (EO) per mole of alcohol. The alcohol radical can be linear or, preferably, methyl-branched in the 2-position, or can contain linear and methyl-branched radicals in a mixture, as is usually the case in oxo alcohol radicals. However, alcohol ethoxylates with linear radicals from alcohols of native origin with 12 to 18 carbon atoms, for example, from coconut, palm, tallow, or oleyl alcohol, and an average of 2 to 8 EO per mole of alcohol are particularly preferred.Preferred ethoxylated alcohols include, for example, C12-C14 alcohols with 3 EO, 4 EO, or 7 EO, C9-C11 alcohols with 7 EO, C13-C15 alcohols with 3 EO, 5 EO, 7 EO, or 8 EO, C12-C18 alcohols with 3 EO, 5 EO, or 7 EO, and mixtures thereof, such as mixtures of C12-C14 alcohols with 3 EO and C12-C18 alcohols with 7 EO. The stated degrees of ethoxylation represent statistical averages, which can be a whole or fractional number for a specific product. Preferred alcohol ethoxylates have a narrow homolog distribution. In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples of these are tallow fatty alcohol with 14 EO, 25 EO, 30 EO, or 40 EO. Nonionic surfactants that contain EO and PO (propylene oxide) groups together in the molecule can also be used. Block copolymers with EO-PO block units or PO-EO block units can be used, as can EO-PO-EO copolymers orPO-EO-PO copolymers.

[0048] Of course, mixed alkoxylated nonionic surfactants can also be used, in which EO and PO units are distributed randomly rather than in blocks. Such products are obtained by the simultaneous action of ethylene oxide and propylene oxide on fatty alcohols.

[0049] Alkyl glycosides can also be used as additional non-ionic surfactants.

[0050] Another class of preferably used nonionic surfactants, which are used either as the sole nonionic surfactant or in combination with other nonionic surfactants, are alkoxylated, preferably ethoxylated or ethoxylated and propoxylated fatty acid alkyl esters, preferably having 1 to 4 carbon atoms in the alkyl chain, in particular fatty acid methyl esters, as described, for example, in Japanese patent application JP 58 / 217598 or which are preferably prepared by the process described in international patent application WO-A-90 / 13533.

[0051] Nonionic surfactants of the amine oxide type, for example N-cocoalkyl-N,N-dimethylamine oxide and N-tallowalkyl-N,N-dihydroxyethylamine oxide, and fatty acid alkanolamides may also be suitable. The amount of these nonionic surfactants is preferably no more than that of the ethoxylated fatty alcohols, in particular no more than half that amount.

[0052] Other suitable surfactants are polyhydroxy fatty acid amides; these are substances that can usually be obtained by reductive amination of a reducing sugar with ammonia, an alkylamine, or an alkanolamine, followed by acylation with a fatty acid, a fatty acid alkyl ester, or a fatty acid chloride. Examples of anionic surfactants used include sulfonate and sulfate surfactants. Preferred sulfonate surfactants are C9-C13 alkylbenzenesulfonates, olefinsulfonates, i.e., mixtures of alkene and hydroxyalkanesulfonates, and disulfonates, such as those obtained, for example, from C12-C18 monoolefins with a terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acidic hydrolysis of the sulfonation products.Alkanesulfonates obtained from C12-C18 alkanes, for example, by sulfochlorination or sulfoxidation followed by hydrolysis or neutralization, are also suitable. Esters of α-sulfofatty acids (estersulfonates), such as the α-sulfonated methyl esters of hydrogenated coconut, palm kernel, or tallow fatty acids, are also suitable.

[0053] Other suitable anionic surfactants are sulfated fatty acid glycerol esters. Fatty acid glycerol esters are understood to be the mono-, di-, and triesters, as well as mixtures thereof, as obtained by esterification of a monoglycerol with 1 to 3 mol of fatty acid or by transesterification of triglycerides with 0.3 to 2 mol of glycerol. Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids with 6 to 22 carbon atoms, for example, caproic acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid, or behenic acid.

[0054] Preferred alk(en)yl sulfates are the alkali metal salts, especially the sodium salts, of the sulfuric acid half-esters of C12-C18 fatty alcohols, for example, coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl, or stearyl alcohol, or C10-C20 oxo alcohols, and those half-esters of secondary alcohols with these chain lengths. Also preferred are alk(en)yl sulfates of the stated chain length that contain a synthetic, petrochemically produced straight-chain alkyl radical, which exhibit degradation behavior similar to that of equivalent compounds based on oleochemical raw materials. For washing purposes, C12-C16 alkyl sulfates and C12-C18 alkyl sulfates, as well as C14-C18 alkyl sulfates, are preferred. 2,3-Alkyl sulfates, which are produced, for example, according to US patents 3,234,258 or 5,075,041 and can be obtained as commercial products from the Shell Oil Company under the name DAN ®<, are also suitable anionic surfactants.Sulfuric acid monoesters of straight-chain or branched C7-C20 alcohols ethoxylated with 1 to 6 mol of ethylene oxide, such as 2-methyl-branched C9-C11 alcohols with an average of 3.5 mol of ethylene oxide (EO) or C12-C18 fatty alcohols with 1 to 4 EO, are also suitable. Due to their high foaming behavior, they are used in cleaning agents only in relatively small amounts, for example, in amounts of 1 to 5 wt.%.

[0055] Other suitable anionic surfactants include the salts of alkyl sulfosuccinic acid, also known as sulfosuccinates or sulfosuccinic acid esters, which are monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and especially ethoxylated fatty alcohols. Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures thereof. Particularly preferred sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols. Sulfosuccinates whose fatty alcohol residues are derived from ethoxylated fatty alcohols with a narrow homolog distribution are particularly preferred. It is also possible to use alk(en)ylsuccinic acid, preferably with 8 to 18 carbon atoms in the alk(en)yl chain, or salts thereof.

[0056] Particularly preferred anionic surfactants are soaps. Suitable examples include saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid, and behenic acid, as well as, in particular, soap mixtures derived from natural fatty acids, for example, coconut, palm kernel, olive oil, or tallow fatty acids.

[0057] The anionic surfactants, including soaps, can be present in the form of their sodium, potassium, or ammonium salts, as well as soluble salts of organic bases, such as mono-, di-, or triethanolamine. The anionic surfactants are preferably present in the form of their sodium or potassium salts, especially in the form of the sodium salts.

[0058] According to the invention, surface-active compounds which can be used as amphoteric surfactants are those which contain at least one quaternary ammonium group and at least one -COO-<- or -SO3-<- group in the molecule. Particularly preferred amphoteric surfactants in this context are betaine surfactants such as alkyl or alkylamidopropyl betaines. Particularly suitable here are betaines such as N-alkyl-N,N-dimethylammonium glycinates, e.g., cocoalkyl dimethylammonium glycinate, N-acyl-aminopropyl-N,N-dimethylammonium glycinates, e.g., For example, cocoacylaminopropyldimethylammonium glycinate, C12-C18 alkyldimethylacetobetaine, cocoamidopropyldimethylacetobetaine, 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines and sulfobetaines each having 8 to 18 C atoms in the alkyl or acyl group, as well as cocoacylaminoethylhydroxyethylcarboxymethylglycinate are preferred.A particularly preferred zwitterionic surfactant is N,N-dimethyl-N-(lauroylamidopropyl)ammonium acetobetaine, known under the INCI name Cocamidopropyl Betaine.

[0059] Other suitable amphoteric surfactants are the group of amphoacetates and amphodiacetates, in particular, for example, coco- or laury amphoacetates or diacetates, the group of amphopropionates and amphodipropionates and the group of amino acid-based surfactants such as acylglutamates, in particular disodium cocoyl glutamate and sodium cocoyl glutamate, acylglycinates, in particular cocoyl glycinate, and acylsarcosinates, in particular ammonium lauroyl sarcosinate and sodium cocoyl sarcosinate.

[0060] The formulations according to the invention particularly preferably contain a fragrance.

[0061] The formulations according to the invention may further contain at least one additional component selected from the group of Emollients, emulsifiers, thickeners / viscosity regulators / stabilizers, UV light protection filters, antioxidants, hydrotropes (or polyols), solids and fillers, film formers, pearlescent additives, deodorant and antiperspirant active ingredients, insect repellents, self-tanning agents, preservatives, conditioning agents, dyes, cosmetic active ingredients, care additives, superfatting agents, solvents.

[0062] Substances that can be used as exemplary representatives of the individual groups are known to the person skilled in the art and can be found, for example, in German application DE 102008001788.4. This patent application is hereby incorporated by reference and is therefore considered part of the disclosure.

[0063] With regard to further optional components and the amounts of these components used, reference is expressly made to the relevant handbooks known to the person skilled in the art, for example K. Schrader, "Grundlagen und Rezepturen der Kosmetika", 2nd edition, pages 329 to 341, Hüthig Buch Verlag Heidelberg.

[0064] The amounts of the respective additives depend on the intended use.

[0065] Typical framework formulations for the respective applications are known to be state-of-the-art and can be found, for example, in the brochures of the manufacturers of the respective raw materials and active ingredients. These existing formulations can generally be used unchanged. However, if necessary, the desired modifications for adaptation and optimization can be easily made through simple trials.

[0066] The rhamnolipid esters according to the invention and the formulations according to the invention containing the rhamnolipid esters according to the invention can be advantageously used to prepare a surface for shaving.

[0067] A further object of the present invention is the cosmetic use of the rhamnolipid esters according to the invention and / or the formulations according to the invention in shaving applications.

[0068] A further object of the present invention is the cosmetic use of the rhamnolipid esters according to the invention and / or the formulations according to the invention for inhibiting hair growth.

[0069] In the examples given below, the present invention is described by way of example, without limiting the invention, the scope of which can be derived from the entire

[0070] description and the claims, should be limited to the embodiments mentioned in the examples. Examples: Example 1: Production of di-rhamnolipids

[0071] A fermentation with a recombinant strain Pseudomonas putida KT2440S pBBR1MCS2-Plac-rhlABC-T-Ptac-rhlC-Twas carried out. The construction of the strain is described in US2014296168. The preculture in a shake flask was carried out as described in WO2012013554. A mineral medium (M9) was also used for the main culture. Fermentation is carried out in a glucose-limited fed-batch process in a 2-liter fermenter. Glucose feeding is regulated based on the dissolved oxygen signal. The oxygen partial pressure of the fermentation broth was regulated at 20% saturation via the stirrer speed. The pH is regulated to 7 using a pH electrode and the addition of 2M sulfuric acid or a 20 wt% ammonia solution. To prevent foaming of the fermentation broth, the defoamer DOW Corning 1500 was added as needed. Fermentation was carried out over 4 days until a dry biomass mass of 15 g / l was reached. The rhamnolipid concentration was determined by HPLC and was 9.8 g / l. After separation of the cells by centrifugation at 10000 g, the fermentation broth was adjusted to a pH of 3.1 by adding concentrated H 2 SO 4. By centrifuging again at 0 °C, a pasty solid concentrate with an active ingredient content of 45 wt. % and a viscosity of > 10,000 mPas was obtained. With constant stirring, a 50 wt. % aqueous KOH solution was added to the pasty suspension of the concentrated rhamnolipid precipitate and a pH of 6 was adjusted. This resulted in the pasty mass liquefying, which was accompanied by a sharp drop in viscosity. The suspension became a clear solution. By adding water, the solution was adjusted to an active ingredient content of 35 wt. %. The rhamnolipid purity was > 90 wt. % based on the dry mass.

[0072] Rhamnolipid species detected by HPLC were: Total RL [%] (HPLC) 91 diRL-C8C10 13,9 monoRL-C8C10 0,51 diRL-C10C10 61,4 monoRL -C10C10 1,4 diRL-C10C12:1 5,9 diRL-C10C12 5,5 other RL 2,2 Example 2: Production of mono-rhamnolipids

[0073] The 35 wt% rhamnolipid solution prepared as described above was diluted to 1% by adding water. Two liters of this solution were heated to 50°C. 200 units of a thermostable rhamnosidase (ThermoActiveTM Rhamnosidase A, Prokazyme) were added with gentle stirring, and the reaction was carried out overnight. After 20 hours, a sample of the solution was analyzed by HPLC. The di-rhamnolipid had been completely converted to mono-rhamnolipid and rhamnose. The enzyme was then inactivated at 80°C for one hour. The entire mixture was then freeze-dried. The freeze-dried product was adjusted to a mono-rhamnolipid active content of 35 wt% by adding water. Example 3: Synthesis of di-rhamnolipid lauryl ester

[0074] To activate the acid function, 25 g of di-rhamnolipid from Example 1 are dissolved with 6.25 ml of diisopropylcarbodiimide in THF at 55°C. If the mixture reaches an acid number of <2, 6.5 g of dodecyl alcohol are added, as is 1 wt% 4-dimethylaminopyridine for catalysis. Any unreacted coupling reagent should be inactivated beforehand by adding 2 ml of water. After a reaction time of 10 h, the reaction mixture is worked up. The reaction mixture is dried on a rotary evaporator (45°C, <300 mbar). Purification is carried out by shaking with ethyl acetate (1): water (1) in two steps of 250 ml each. The rhamnolipid ester remains in the ethyl acetate phase. This phase is also dried on a rotary evaporator (45°C, <100 mbar), leaving the viscous rhamnolipid ester.

[0075] Further purification of the product can be achieved by column chromatography. Silica 60 gel (SIGMA Aldrich) serves as the stationary phase and ethyl acetate (99):water (1) with 1% acetic acid as the mobile phase. Polar by-products or possible cleavage products are removed from a 5% solution of the crude rhamnolipid ester product. For thorough separation, one fraction comprises 10 ml at a drop rate of 15 ml / min and a total volume of 200 ml of starting solution.

[0076] Analytical determination by HPLC was carried out on a 50*3.0 mm column Poroshell 120 C18 (2.7µm) in 20mM NH 4 formate in H 2 O and MeCN at 30°C for 35 min. Example 4: Non-inventive synthesis of rhamnolipid esters

[0077] The synthesis was carried out according to the procedure from the publication Miao et al. European Journal of Lipid Science and Technology, 117, 2015; 156-1609.

[0078] For this purpose, di-rhamnolipid from Example 1 was reacted with ethanol and sulfuric acid at 0 °C as described in the literature. The observed yield was less than 5%.

[0079] This is due, among other things, to the lack of coupling reagent.

[0080] A synthesis of long-chain rhamnolipid esters with C12 fatty alcohol at low temperatures was not possible, as this is in the solid state at 0 °C, and thus esterification is not possible; the conversion is 0%. At an increase in temperature, degradation of the reactant occurs, and no rhamnolipid esters are formed; the conversion is 0%. Example 5: Description of the application effects and the formulation

[0081] In order to measure the influence of the above-mentioned structures on hair growth after shaving with shaving foam and cream formulations according to the invention, the following standardized application test was carried out with a trained panel of at least 33 panelists.

[0082] For this purpose, the panelists were provided with shaving foam and cream formulations (see formulations 1-6) in anonymized pump dispensers for a home-use test. The panel was initially divided into two subgroups, a (men) and b (women). The shaving tests were conducted as half-side shave tests, with subgroup a assessing the effect on facial beard growth and subgroup b assessing the effect on hair growth on the lower legs. Group a: Shaving foam for sensitive skin

[0083] Formulation 1 according to the invention. Formulation 2 Formulation 5 Water 66,5 66,5 66,5 disodium lauroamphodiacetate; Sodium Lauryl sulfate, Hexylene Glycol 18,6 20,0 18,6 Disodium PEG-4 Cocamide MIPAsulfosuccinate 10,0 10,0 10 Cocamide MEA 3,0 3,0 3,0 Ricinolamidopropyltrimonium Methosulfate 0,5 0,5 0,5 Rhamnolipid esters from Example 3 1,4 Rhamnolipid ethyl ester from Example 4. 1,4 Sodium hydroxide (10% in water, up to pH 8-8.5) qs qs qs Preservatives qs qs qs Group b: Shaving foam for delicate skin

[0084] Formulation 3 according to the invention Formulation 4 Formulation 6 Water 76,5 76,5 76,5 Coconut fatty acid 1,4 1,4 1,4 Monoethanolamine 1,3 1,3 1,3 Myristic acid 3,5 3,5 3,5 Sucrose Cocoate 2,0 2,0 2,0 Capryl / Capramidopropyl Betaine 6,4 7,6 6,4 Rhamnolipid esters from Example 3 1,2 Rhamnolipid ethyl ester from Example 4 1,2 Glycerin 5,0 5,0 5,0 Bis-PEG / PPG-20 / 20 Dimethicon 1,7 1,7 1,7 Perfume 0,3 0,3 0,3 Hydroxypropyl Methylcellulose 0,7 0,7 0,7 Sodium hydroxide (10% in water, up to pH 8.5) qs qs qs Preservatives qs qs qs Group a

[0085] The face was cleansed and moistened in preparation for shaving. One pump of the corresponding formulation was evenly applied to each half of the face. After a contact time of 60 + / - 5 seconds, the hair was removed using a Balea 2-blade disposable razor. The face was then washed with water and dried. The resulting skin sensation was assessed once after 3 minutes and again after 8 hours + / - 30 minutes, and rated on a scale of 1 to 3. 1 Silky, soft skin feeling; smooth 2 Less smooth, but no noticeable stubble 3 Noticeable stubble; scratchy skin feeling Group b

[0086] The lower legs were cleansed and moistened in preparation for shaving. Three pumps of the corresponding formulations were evenly applied to each lower leg. After a contact time of 60 + / - 5 seconds, the hair was removed using a Balea 2-blade disposable razor. The legs were then washed with water and dried. The resulting skin sensation was assessed once after 3 minutes and again after 24 hours, scoring it on a scale of 1 to 3. 1 Silky, soft skin feeling; smooth 2 Less smooth, but no noticeable hairs 3 Noticeable hairs; scratchy skin feeling

[0087] The following table compares the results of the sensory assessment of the skin on the face (group a) and on the lower leg (group b) after shaving with the inventive formulations 1 and 3 with the results of the comparative formulations 2 and 4 as well as 5 and 6: formulation 1 required 2 3 req 4 5 6 Group a, after 3 minutes 1,3 1,6 1,5 Group a, after 8 hours 1,7 2,5 2,3 Group b, after 3 minutes 1,2 1,4 1,6 Group b, after 24 hours 1,8 2,2 2,4

[0088] Surprisingly, it was found that after applying the formulations 1 and 3 according to the invention, the smooth, silky-soft skin feeling directly after shaving is maintained for significantly longer than after applying the comparative formulations 2 and 4 as well as 5 and 6.

Claims

1. Rhamnolipid esters of the general formula (I), where m = 2, 1 or 0, in particular 1 or 0, n = 1 or 0, in particular 1, R1 = organic radical having 2 to 24, preferably 5 to 13, carbon atoms, selected from optionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, bi- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH2)o-CH3 where o = 1 to 23, preferably 4 to 12, R2 = independently of one another identical or different organic radical having 2 to 24, preferably 5 to 13, carbon atoms, selected from optionally branched, optionally hydroxy-substituted, optionally unsaturated, in particular optionally mono-, bi- or tri-unsaturated, alkyl radical, preferably those selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH2)o-CH3 where o = 1 to 23, preferably 4 to 12, and R3 = aliphatic radical having 7 to 32 carbon atoms, characterized in that R3 is selected from the group of the radicals R3 derived from OHR3 = natural fatty alcohol.

2. Rhamnolipid esters according to Claim 1, characterized in that R3 is selected from branched or linear alkyl radicals.

3. Rhamnolipid esters according to Claim 1 or 2, characterized in that R3 is selected from branched or linear alkyl radicals having 8 to 22, in particular 12 to 18, carbon atoms.

4. Rhamnolipid esters according to at least one of the preceding claims, characterized in that R3 is selected from the group comprising, preferably consisting of, lauryl, myristyl, palmityl and stearyl radicals.

5. Process for the preparation of rhamnolipid esters according to Claim 1, comprising the process steps A) provision of at least one rhamnolipid, B) reaction of the rhamnolipid with at least one coupling reagent, C) reaction of the rhamnolipid activated by process step B) with an alcohol selected from the group of aliphatic alcohols having 7 to 32 carbon atoms and fatty alcohols, and optionally D) purification of the rhamnolipid ester.

6. Process according to Claim 5, characterized in that in process step B) the coupling reagent used is at least one selected from the group comprising, preferably consisting of, dicyclohexylcarbodiimide, diisopropylcarbodiimide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-cyclohexyl-N'-(2'-morpholinoethyl)carbodiimide metho-p-toluenesulfonate, N-benzyl-N'-3'-dimethylaminopropylcarbodiimide hydrochloride, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, N-ethylcarbodiimide hydrochloride and carbonyldiimidazole, especially preferably dicyclohexylcarbodiimide and diisopropylcarbodiimide.

7. Process according to Claim 5 or 6, characterized in that in process step C) at least one catalyst selected from the group comprising, preferably consisting of, N-ethyldiisopropylamine, trialkylamines, pyridine, 4-dimethylaminopyridine and hydroxybenzotriazole, in particular hydroxybenzotriazole, is used.

8. Formulation, in particular a cosmetic formulation, comprising at least one rhamnolipid ester according to at least one of Claims 1 to 4.

9. Cosmetic use of a rhamnolipid ester according to at least one of Claims 1 to 4 or of a formulation according to Claim 8 in shaving applications.

10. Cosmetic use of a rhamnolipid ester according to at least one of Claims 1 to 4 or of a formulation according to Claim 8 in formulations for inhibiting hair growth.